Clinical Trial 22359

Cancer Type: Malignant Hematology
Study Type: Other
NCT#:

Phase: N/A
Principal Investigator: Oswald, Laura

Call 813-745-6100
or 1-800-679-0775 Learn More

Overview

Study Title

Sexual Health in Adolescent and Young Adult Patients after Chimeric Antigen Receptor T-Cell Therapy

Summary

The purpose of the study is to examine sexual health among young adult cancer survivors aged 18-39 years after chimeric antigen receptor T-cell (CAR-T) therapy. Investigators will also examine how health care providers communicate with patients about issues with their sexual health.

Objective

Our specific aims are to: Aim 1. Examine sexual health (i.e., sexual activity, dysfunction, and satisfaction) after CAR T-cell therapy among AYA cancer patients. Aim 2. Explore relationships between sexual health and other domains of HRQOL after CAR T-cell therapy among AYA cancer patients. Aim 3. Explore communication about sexual health between AYA recipients of CAR T-cell therapy and their healthcare providers.

Treatments

Therapies

Medications

Inclusion Criteria

18-39 years old

Have undergone CAR T-cell therapy at Moffitt Cancer Center within the past 3 years

Have an expected survival of at least 3 months

Are able to speak and read English or Spanish

Have no documented or observational psychiatric or neurological disorders that could interfere with study participation (e.g., psychosis)

Are able to provide informed consent

Exclusion Criteria

Does not meet inclusion criteria

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

Clinical Trials Search

Advanced Search